AM-855
![]() | |
Systematic (IUPAC) name | |
---|---|
(4aR,12bR)-8-hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol | |
Identifiers | |
CAS Number | 249888-50-4 |
PubChem | CID 10091328 |
ChemSpider |
8266865 ![]() |
ChEMBL |
CHEMBL303479 ![]() |
Chemical data | |
Formula | C26H38O2 |
Molar mass | 382.577 g/mol |
| |
| |
(verify) |
AM-855 (part of the AM cannabinoid series) is an analgesic drug which is a cannabinoid agonist. It is a derivative of Δ8Tetrahydrocannabinol with a conformationally restricted side chain which has been bound into a fourth ring fused to the aromatic A-ring of the cannabinoid skeleton. AM-855 is an agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 22.3nM at CB1 and 58.6nM at CB2.[1]
References
- ↑ Khanolkara, Atmaram D.; Lua, Dai; Fana, Pusheng; Tiana, Xiaoyu; Makriyannis, Alexandros (August 1999). "Novel conformationally restricted tetracyclic analogs of Δ8-tetrahydrocannabinol". Bioorganic & Medicinal Chemistry Letters 9 (15): 2119–24. doi:10.1016/S0960-894X(99)00355-8. PMID 10465529.
This article is issued from Wikipedia - version of the Wednesday, February 17, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.